Barcelona, Spain, April 28, 2017. Stem cells from healthy young donors, delivered via intravenous infusion to frail older adults, were shown to reduce inflammation in a small pilot study reported today at the International Conference on Frailty and Sarcopenia Research (ICFSR).  “These findings suggest that stem cells may have the potential to reverse some of the most debilitating effects of aging that result from chronic inflammation and a decline in immune function”, according to Joshua M. Hare, M.D., Chief Science Officer of Longeveron LLC and Director of the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine.

Press release 1-2017